Development of serological assays to detect SARS-CoV-2 antibodies

Scientists from the Institut Pasteur, the CNRS, Inserm and Université de Paris conducted a pilot study to evaluate the reliability of several laboratory tests with the aim of gaining a better understanding of the profile of antibody responses to SARS-CoV-2 and how the virus is spreading among the population. Four tests for the detection of SARS-CoV-2 antibodies were developed and evaluated, as well as two tests for the detection of neutralizing antibodies.